{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:40:32Z","timestamp":1792291232315,"version":"4.4.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12035-015-9110-9","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T01:12:12Z","timestamp":1425863532000},"page":"1862-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?"],"prefix":"10.1007","volume":"52","author":[{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Febo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis K.","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fratantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"issue":"1","key":"9110_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2012.662105","volume":"44","author":"DE Smith","year":"2012","unstructured":"Smith DE (2012) The process addictions and the new ASAM definition of addiction. J Psychoactive Drugs 44(1):1\u20134","journal-title":"J Psychoactive Drugs"},{"key":"9110_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-7230-8","volume-title":"Molecular neurobiology of addiction recovery: the 12 step program and fellowship","author":"K Blum","year":"2013","unstructured":"Blum K, Femino J, Teitelbaum S, Giordano J, Oscar-Berman M, Gold MS (2013) Molecular neurobiology of addiction recovery: the 12 step program and fellowship. Springer, New York"},{"issue":"4","key":"9110_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tics.2014.01.010","volume":"18","author":"AM Belcher","year":"2014","unstructured":"Belcher AM, Volkow ND, Moeller FG, Ferr\u00e9 S (2014) Personality traits and vulnerability or resilience to substance use disorders. Trends Cogn Sci 18(4):211\u2013217","journal-title":"Trends Cogn Sci"},{"issue":"3","key":"9110_CR4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/add.12040","volume":"108","author":"S McDonald","year":"2013","unstructured":"McDonald S, Darke S, Kaye S, Torok M (2013) Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users. Addiction 108(3):566\u2013574","journal-title":"Addiction"},{"key":"9110_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroimage.2013.10.021","volume":"88","author":"M Li","year":"2014","unstructured":"Li M, Tian J, Zhang R, Qiu Y, Wen X, Ma X, Wang J, Xu Y, Jiang G, Huang R (2014) Abnormal cortical thickness in heroin-dependent individuals. Neuroimage 88:295\u2013307","journal-title":"Neuroimage"},{"issue":"3","key":"9110_CR6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.drugalcdep.2012.05.030","volume":"126","author":"X Wang","year":"2012","unstructured":"Wang X, Li B, Zhou X, Liao Y, Tang J, Liu T, Hu D, Hao W (2012) Changes in brain gray matter in abstinent heroin addicts. Drug Alcohol Depend 126(3):304\u2013308","journal-title":"Drug Alcohol Depend"},{"key":"9110_CR7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/NDT.S52298","volume":"9","author":"RB Luhar","year":"2013","unstructured":"Luhar RB, Sawyer KS, Gravitz Z, Ruiz SM, Oscar-Berman M (2013) Brain volumes and neuropsychological performance are related to current smoking and alcoholism history. Neuropsychiatr Dis Treat 9:1767\u20131784","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9110_CR8","doi-asserted-by":"crossref","unstructured":"Bell RP, Foxe JJ, Ross LA, Garavan H (2013) Intact inhibitory control processes in abstinent drug abusers (I): a functional neuroimaging study in former cocaine addicts. Neuropharmacology","DOI":"10.1016\/j.neuropharm.2013.02.018"},{"key":"9110_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnhum.2011.00058","volume":"5","author":"A Horstmann","year":"2011","unstructured":"Horstmann A, Busse FP, Mathar D, M\u00fcller K, Lepsien J, Schl\u00f6gl H, Kabisch S, Kratzsch J, Neumann J, Stumvoll M, Villringer A, Pleger B (2011) Obesity-related differences between women and men in brain structure and goal-directed behavior. Front Hum Neurosci 5:58","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"9110_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jpsychires.2012.01.004","volume":"46","author":"DH Han","year":"2012","unstructured":"Han DH, Lyoo IK, Renshaw PF (2012) Differential regional gray matter volumes in patients with on-line game addiction and professional gamers. J Psychiatr Res 46(4):507\u2013515","journal-title":"J Psychiatr Res"},{"issue":"1","key":"9110_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217\u2013238","journal-title":"Neuropsychopharmacology"},{"key":"9110_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fpsyt.2014.00016","volume":"5","author":"MJ McHugh","year":"2014","unstructured":"McHugh MJ, Demers CH, Salmeron BJ, Devous MD Sr, Stein EA, Adinoff B (2014) Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry 5:16","journal-title":"Front Psychiatry"},{"issue":"2","key":"9110_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000170586","volume":"89","author":"LM Davis","year":"2009","unstructured":"Davis LM, Michaelides M, Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough K, Hope B, Wang GJ, Volkow ND, Thanos PK (2009) Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 89(2):152\u2013162","journal-title":"Neuroendocrinology"},{"issue":"6","key":"9110_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1037\/a0014103","volume":"16","author":"RB Rothman","year":"2008","unstructured":"Rothman RB, Blough BE, Baumann MH (2008) Dual dopamine\/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol 16(6):458\u2013474","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"9110_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3810\/pgm.2014.01.2735","volume":"126","author":"MS Gold","year":"2014","unstructured":"Gold MS, Blum K, Oscar-Berman M, Braverman ER (2014) Low dopamine function in attention deficit\/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med 126(1):153\u2013177","journal-title":"Postgrad Med"},{"issue":"2","key":"9110_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/02791072.2011.587393","volume":"43","author":"TJ Chen","year":"2011","unstructured":"Chen TJ, Blum K, Chen AL, Bowirrat A, Downs WB, Madigan MA, Waite RL, Bailey JA, Kerner M, Yeldandi S, Majmundar N, Giordano J, Morse S, Miller D, Fornari F, Braverman ER (2011) Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map. J Psychoactive Drugs 43(2):108\u2013127","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"9110_CR17","first-page":"139","volume":"3","author":"K Blum","year":"2012","unstructured":"Blum K, Oscar-Berman M, Stuller E, Miller D, Giordano J, Morse S, McCormick L, Downs WB, Waite RL, Barh D, Neal D, Braverman ER, Lohmann R, Borsten J, Hauser M, Han D, Liu Y, Helman M, Simpatico T (2012) Neurogenetics and nutrigenomics of neuro-nutrient therapy for reward deficiency syndrome (RDS): clinical ramifications as a function of molecular neurobiological mechanisms. J Addict Res Ther 3(5):139","journal-title":"J Addict Res Ther"},{"issue":"3","key":"9110_CR18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.mehy.2004.02.051","volume":"63","author":"TJ Chen","year":"2004","unstructured":"Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER (2004) Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy. Med Hypotheses 63(3):538\u2013548","journal-title":"Med Hypotheses"},{"issue":"6","key":"9110_CR19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3810\/pgm.2010.11.2237","volume":"122","author":"K Blum","year":"2010","unstructured":"Blum K, Chen TJ, Morse S, Giordano J, Chen AL, Thompson J, Allen C, Smolen A, Lubar J, Stice E, Downs BW, Waite RL, Madigan MA, Kerner M, Fornari F, Braverman ER (2010) Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D2 agonist therapy: part 2. Postgrad Med 122(6):214\u2013226","journal-title":"Postgrad Med"},{"issue":"6","key":"9110_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3810\/pgm.2010.11.2236","volume":"122","author":"DK Miller","year":"2010","unstructured":"Miller DK, Bowirrat A, Manka M, Miller M, Stokes S, Manka D, Allen C, Gant C, Downs BW, Smolen A, Stevens E, Yeldandi S, Blum K (2010) Acute intravenous synaptamine complex variant KB220\u2122 \u201cnormalizes\u201d neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. Postgrad Med 122(6):188\u2013213","journal-title":"Postgrad Med"},{"key":"9110_CR21","doi-asserted-by":"crossref","unstructured":"Dani JA, De Biasi M (2013) Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal. Cold Spring Harb Perspect Med 3(6)","DOI":"10.1101\/cshperspect.a012138"},{"issue":"6","key":"9110_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3810\/pgm.2009.11.2087","volume":"121","author":"K Blum","year":"2009","unstructured":"Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M (2009) Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing \u201cdeprivation-amplification relapse therapy\u201d (DART). Postgrad Med 121(6):176\u2013196","journal-title":"Postgrad Med"},{"issue":"5","key":"9110_CR23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/alcalc\/agr045","volume":"46","author":"A Dahlgren","year":"2011","unstructured":"Dahlgren A, Wargelius HL, Berglund KJ, Fahlke C, Blennow K, Zetterberg H, Oreland L, Berggren U, Balldin J (2011) Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol Alcohol 46(5):509\u2013513","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"9110_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/alcalc\/agp041","volume":"45","author":"U Berggren","year":"2010","unstructured":"Berggren U, Fahlke C, Berglund KJ, Wadell K, Zetterberg H, Blennow K, Thelle D, Balldin J (2010) Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals. Alcohol Alcohol 45(1):1\u20135","journal-title":"Alcohol Alcohol"},{"key":"9110_CR25","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1038\/tp.2012.146","volume":"3","author":"D Sullivan","year":"2013","unstructured":"Sullivan D, Pinsonneault JK, Papp AC, Zhu H, Lemeshow S, Mash DC, Sadee W (2013) Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Transl Psychiatry 3:e222","journal-title":"Transl Psychiatry"},{"issue":"3","key":"9110_CR26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","volume":"9","author":"CA Dackis","year":"1985","unstructured":"Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9(3):469\u2013477","journal-title":"Neurosci Biobehav Rev"},{"issue":"15","key":"9110_CR27","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.1990.03440150063027","volume":"263","author":"K Blum","year":"1990","unstructured":"Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263(15):2055\u20132060","journal-title":"JAMA"},{"issue":"9","key":"9110_CR28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archpsyc.63.9.999","volume":"63","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK (2006) High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 63(9):999\u20131008","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"9110_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008571-199608000-00003","volume":"6","author":"K Blum","year":"1996","unstructured":"Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, Taub M, Montgomery AR, Sheridan PJ, Cull JG (1996) Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 6(4):297\u2013305","journal-title":"Pharmacogenetics"},{"issue":"9253","key":"9110_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","volume":"357","author":"GJ Wang","year":"2001","unstructured":"Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357(9253):354\u2013357","journal-title":"Lancet"},{"issue":"1","key":"9110_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neubiorev.2007.04.019","volume":"32","author":"NM Avena","year":"2008","unstructured":"Avena NM, Rada P, Hoebel BG (2008) Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32(1):20\u201339","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"9110_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FBP.0000000000000029","volume":"25","author":"ME Bocarsly","year":"2014","unstructured":"Bocarsly ME, Hoebel BG, Paredes D, von Loga I, Murray SM, Wang M, Arolfo MP, Yao L, Diamond I, Avena NM (2014) GS 455534 selectively suppresses binge eating of palatable food and attenuates dopamine release in the accumbens of sugar-bingeing rats. Behav Pharmacol 25(2):147\u2013157","journal-title":"Behav Pharmacol"},{"key":"9110_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000324065","volume":"30","author":"EL Gardner","year":"2011","unstructured":"Gardner EL (2011) Addiction and brain reward and anti-reward pathways. Adv Psychosom Med 30:22\u201360","journal-title":"Adv Psychosom Med"},{"issue":"Suppl 1","key":"9110_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","volume":"56","author":"GF Koob","year":"2009","unstructured":"Koob GF (2009) Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56(Suppl 1):18\u201331","journal-title":"Neuropharmacology"},{"key":"9110_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","volume":"109","author":"I Elman","year":"2013","unstructured":"Elman I, Borsook D, Volkow ND (2013) Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol 109:1\u201327","journal-title":"Prog Neurobiol"},{"issue":"2","key":"9110_CR36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/02791072.2012.685407","volume":"44","author":"K Blum","year":"2012","unstructured":"Blum K, Chen AL, Giordano J, Borsten J, Chen TJ, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D (2012) The addictive brain: all roads lead to dopamine. J Psychoactive Drugs 44(2):134\u2013143","journal-title":"J Psychoactive Drugs"},{"key":"9110_CR37","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511581366","volume-title":"The dopaminergic mind in human evolution and history","author":"FH Previc","year":"2009","unstructured":"Previc FH (2009) The dopaminergic mind in human evolution and history. Cambridge University Press, New York"},{"key":"9110_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0925-4927(91)90014-H","volume":"40","author":"B Horwitz","year":"1991","unstructured":"Horwitz B, Swedo SE, Grady CL, Pietrini P, Schapiro MB, Rapoport JL, Rapoport SI (1991) Cerebral metabolic pattern in obsessive-compulsive disorder: altered intercorrelations between regional rates of glucose utilization. Psychiatry Res 40:221\u2013237","journal-title":"Psychiatry Res"},{"issue":"1","key":"9110_CR39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2008.05.008","volume":"155","author":"MA Raghanti","year":"2008","unstructured":"Raghanti MA, Stimpson CD, Marcinkiewicz JL, Erwin JM, Hof PR, Sherwood CC (2008) Cortical dopaminergic innervation among humans, chimpanzees, and macaque monkeys: a comparative study. Neuroscience 155(1):203\u2013220","journal-title":"Neuroscience"},{"key":"9110_CR40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ncomms1603","volume":"2","author":"DK Adams","year":"2011","unstructured":"Adams DK, Sewell MA, Angerer RC, Angerer LM (2011) Rapid adaptation to food availability by a dopamine-mediated morphogenetic response. Nat Commun 2:592","journal-title":"Nat Commun"},{"issue":"3","key":"9110_CR41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/dvdy.20075","volume":"230","author":"W Boehmler","year":"2004","unstructured":"Boehmler W, Obrecht-Pflumio S, Canfield V, Thisse C, Thisse B, Levenson R (2004) Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. Dev Dyn 230(3):481\u2013493","journal-title":"Dev Dyn"},{"issue":"7","key":"9110_CR42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","volume":"48","author":"EP Noble","year":"1991","unstructured":"Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48(7):648\u2013654","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"9110_CR43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138161212798919110","volume":"18","author":"K Blum","year":"2012","unstructured":"Blum K, Gardner E, Oscar-Berman M, Gold M (2012) \u201cLiking\u201d and \u201cwanting\u201d linked to reward deficiency syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des 18(1):113\u2013118","journal-title":"Curr Pharm Des"},{"issue":"1","key":"9110_CR44","first-page":"37","volume":"10","author":"K Blum","year":"1995","unstructured":"Blum K, Wood RC, Braverman ER, Chen TJ, Sheridan PJ (1995) The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes\u2019 theorem. Funct Neurol 10(1):37\u201344","journal-title":"Funct Neurol"},{"issue":"10\u201312","key":"9110_CR45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1081\/JA-200033194","volume":"39","author":"S Sussman","year":"2004","unstructured":"Sussman S, Stacy AW, Johnson CA, Pentz MA, Robertson E (2004) A transdisciplinary focus on drug abuse prevention: an introduction. Subst Use Misuse 39(10\u201312):1441\u20131456","journal-title":"Subst Use Misuse"},{"key":"9110_CR46","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a CJ, Bagot RC, Labont\u00e9 B, Nestler EJ (2014) Epigenetic signaling in psychiatric disorders. J Mol Biol","DOI":"10.1016\/j.jmb.2014.03.016"},{"issue":"3","key":"9110_CR47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1530-0277.2010.01369.x","volume":"35","author":"R Gueorguieva","year":"2011","unstructured":"Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O\u2019Malley SS (2011) Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study. Alcohol Clin Exp Res 35(3):523\u2013531","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"9110_CR48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00210-002-0674-3","volume":"367","author":"MJ Cano-Cebri\u00e1n","year":"2003","unstructured":"Cano-Cebri\u00e1n MJ, Zornoza-Sabina T, Guerri C, Polache A, Granero L (2003) Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 367(2):119\u2013125","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"9110_CR49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.drugalcdep.2013.01.003","volume":"129","author":"KL Shelton","year":"2013","unstructured":"Shelton KL, Hendrick ES, Beardsley PM (2013) Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats. Drug Alcohol Depend 129(3):210\u2013216","journal-title":"Drug Alcohol Depend"},{"issue":"163","key":"9110_CR50","first-page":"1000163","volume":"4","author":"K Blum","year":"2013","unstructured":"Blum K, Oscar-Berman M, Dinubile N, Giordano J, Braverman ER, Truesdell CE, Barh D, Badgaiyan R (2013) Coupling genetic addiction risk score (GARS) with electrotherapy: fighting iatrogenic opioid dependence. J Addict Res Ther 4(163):1000163","journal-title":"J Addict Res Ther"},{"issue":"9","key":"9110_CR51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jinsphys.2010.03.014","volume":"56","author":"EV Bogomolova","year":"2010","unstructured":"Bogomolova EV, Rauschenbach IY, Adonyeva NV, Alekseev AA, Faddeeva NV, Gruntenko NE (2010) Dopamine down-regulates activity of alkaline phosphatase in drosophila: the role of D2-like receptors. J Insect Physiol 56(9):1155\u20131159","journal-title":"J Insect Physiol"},{"issue":"3","key":"9110_CR52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.3232-13.2014","volume":"34","author":"EP Maguire","year":"2014","unstructured":"Maguire EP, Macpherson T, Swinny JD, Dixon CI, Herd MB, Belelli D, Stephens DN, King SL, Lambert JJ (2014) Tonic inhibition of accumbal spiny neurons by extrasynaptic \u03b14\u03b2\u03b4 GABAA receptors modulates the actions of psychostimulants. J Neurosci 34(3):823\u2013838","journal-title":"J Neurosci"},{"issue":"2","key":"9110_CR53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.112.201012","volume":"344","author":"PW Czoty","year":"2013","unstructured":"Czoty PW, Nader MA (2013) Effects of dopamine D2\/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys. J Pharmacol Exp Ther 344(2):329\u2013338","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"9110_CR54","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/npp.2012.97","volume":"37","author":"AK Radke","year":"2012","unstructured":"Radke AK, Gewirtz JC (2012) Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Neuropsychopharmacology 37(11):2405\u20132415","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"9110_CR55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/syn.20523","volume":"62","author":"PK Thanos","year":"2008","unstructured":"Thanos PK, Michaelides M, Umegaki H, Volkow ND (2008) D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 62(7):481\u2013486","journal-title":"Synapse"},{"issue":"2","key":"9110_CR56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.lfs.2004.10.061","volume":"77","author":"PK Thanos","year":"2005","unstructured":"Thanos PK, Rivera SN, Weaver K, Grandy DK, Rubinstein M, Umegaki H, Wang GJ, Hitzemann R, Volkow ND (2005) Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci 77(2):130\u2013139","journal-title":"Life Sci"},{"issue":"5","key":"9110_CR57","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1471-4159.2001.00492.x","volume":"78","author":"PK Thanos","year":"2001","unstructured":"Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 78(5):1094\u20131103","journal-title":"J Neurochem"},{"issue":"3","key":"9110_CR58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1369-1600.2008.00145.x","volume":"14","author":"CL Crunelle","year":"2009","unstructured":"Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J (2009) Dose-dependent and sustained effects of varenicline on dopamine D2\/3 receptor availability in rats. Addict Biol 14(3):283\u2013293","journal-title":"Addict Biol"},{"issue":"1","key":"9110_CR59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.110.170969","volume":"335","author":"RM Rijn van","year":"2010","unstructured":"van Rijn RM, Brissett DI, Whistler JL (2010) Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther 335(1):133\u2013139","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"9110_CR60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchemneu.2005.07.004","volume":"30","author":"SJ Ribeiro","year":"2005","unstructured":"Ribeiro SJ, Ciscato JG Jr, de Oliveira R, de Oliveira RC, D\u2019Angelo-Dias R, Carvalho AD, Felippotti TT, Rebou\u00e7as EC, Castellan-Baldan L, Hoffmann A, Corr\u00eaa SA, Moreira JE, Coimbra NC (2005) Functional and ultrastructural neuroanatomy of interactive intratectal\/tectonigral mesencephalic opioid inhibitory links and nigrotectal GABAergic pathways: involvement of GABAA and mu1-opioid receptors in the modulation of panic-like reactions elicited by electrical stimulation of the dorsal midbrain. J Chem Neuroanat 30(4):184\u2013200","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"9110_CR61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.euroneuro.2010.11.001","volume":"21","author":"RC Carvalho","year":"2011","unstructured":"Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R (2011) Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors. Eur Neuropsychopharmacol 21(2):205\u2013210","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"9110_CR62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00213-006-0473-5","volume":"191","author":"DL Graham","year":"2007","unstructured":"Graham DL, Hoppenot R, Hendryx A, Self DW (2007) Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats. Psychopharmacology (Berl) 191(3):719\u2013730","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"9110_CR63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00210-004-0937-2","volume":"369","author":"N Milivojevic","year":"2004","unstructured":"Milivojevic N, Krisch I, Sket D, Zivin M (2004) The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats. Naunyn Schmiedebergs Arch Pharmacol 369(6):576\u2013582","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"9110_CR64","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1523\/JNEUROSCI.22-07-02977.2002","volume":"22","author":"SB Caine","year":"2002","unstructured":"Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (2002) Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22(7):2977\u20132988","journal-title":"J Neurosci"},{"issue":"2","key":"9110_CR65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-5846(01)00214-7","volume":"26","author":"LG Schmidt","year":"2002","unstructured":"Schmidt LG, Kuhn S, Smolka M, Schmidt K, Rommelspacher H (2002) Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. Prog Neuropsychopharmacol Biol Psychiatry 26(2):209\u2013217","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"9110_CR66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02247382","volume":"126","author":"R Weissenborn","year":"1996","unstructured":"Weissenborn R, Deroche V, Koob GF, Weiss F (1996) Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology (Berl) 126(4):311\u2013322","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"9110_CR67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm0495-337","volume":"1","author":"BR Lawford","year":"1995","unstructured":"Lawford BR, Young RM, Rowell JA, Qualichefski J, Fletcher BH, Syndulko K, Ritchie T, Noble EP (1995) Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat Med 1(4):337\u2013341","journal-title":"Nat Med"},{"issue":"3","key":"9110_CR68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0922-4106(94)90044-2","volume":"269","author":"GY Ng","year":"1994","unstructured":"Ng GY, George SR (1994) Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL\/6J inbred mouse. Eur J Pharmacol 269(3):365\u2013374","journal-title":"Eur J Pharmacol"},{"issue":"21","key":"9110_CR69","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1073\/pnas.80.21.6510","volume":"80","author":"K Blum","year":"1983","unstructured":"Blum K, Elston SF, DeLallo L, Briggs AH, Wallace JE (1983) Ethanol acceptance as a function of genotype amounts of brain [Met] enkephalin. Proc Natl Acad Sci U S A 80(21):6510\u20136512","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"9110_CR70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.tins.2004.10.001","volume":"27","author":"MA Ungless","year":"2004","unstructured":"Ungless MA (2004) Dopamine: the salient issue. Trends Neurosci 27(12):702\u2013706","journal-title":"Trends Neurosci"},{"issue":"3","key":"9110_CR71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-009-1553-0","volume":"205","author":"N Suto","year":"2009","unstructured":"Suto N, Ecke LE, Wise RA (2009) Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens. Psychopharmacology (Berl) 205(3):431\u2013439","journal-title":"Psychopharmacology (Berl)"},{"issue":"49","key":"9110_CR72","doi-asserted-by":"crossref","first-page":"17917","DOI":"10.1523\/JNEUROSCI.1903-11.2011","volume":"31","author":"N Suto","year":"2011","unstructured":"Suto N, Wise RA (2011) Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core. J Neurosci 31(49):17917\u201317922","journal-title":"J Neurosci"},{"issue":"5","key":"9110_CR73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nn.3694","volume":"17","author":"I Willuhn","year":"2014","unstructured":"Willuhn I, Burgeno LM, Groblewski PA, Phillips PE (2014) Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci 17(5):704\u2013709","journal-title":"Nat Neurosci"},{"issue":"5","key":"9110_CR74","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nn.3699","volume":"17","author":"D Caprioli","year":"2014","unstructured":"Caprioli D, Calu D, Shaham Y (2014) Loss of phasic dopamine: a new addiction marker? Nat Neurosci 17(5):644\u2013646","journal-title":"Nat Neurosci"},{"issue":"5","key":"9110_CR75","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29(5):969\u2013981","journal-title":"Neuropsychopharmacology"},{"issue":"8438","key":"9110_CR76","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(85)92448-1","volume":"1","author":"CA Dackis","year":"1985","unstructured":"Dackis CA, Gold MS (1985) Bromocriptine as treatment of cocaine abuse. Lancet 1(8438):1151\u20131152","journal-title":"Lancet"},{"issue":"8","key":"9110_CR77","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molmed.2008.06.004","volume":"14","author":"W Renthal","year":"2008","unstructured":"Renthal W, Nestler EJ (2008) Epigenetic mechanisms in drug addiction. Trends Mol Med 14(8):341\u2013350","journal-title":"Trends Mol Med"},{"issue":"20","key":"9110_CR78","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.jmb.2014.03.016","volume":"426","author":"CJ Pe\u00f1a","year":"2014","unstructured":"Pe\u00f1a CJ, Bagot RC, Labont\u00e9 B, Nestler EJ (2014) Epigenetic signaling in psychiatric disorders. J Mol Biol 426(20):3389\u20133412","journal-title":"J Mol Biol"},{"key":"9110_CR79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jgg.2013.06.004","volume":"40","author":"M Szyf","year":"2013","unstructured":"Szyf M (2013) DNA methylation, behavior and early life adversity. J Genet Genomics 40:331\u2013338","journal-title":"J Genet Genomics"},{"key":"9110_CR80","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neubiorev.2013.03.020","volume":"37","author":"D Kofink","year":"2013","unstructured":"Kofink D, Boks MP, Timmers HT, Kas MJ (2013) Epigenetic dynamics in psychiatric disorders: environmental programming of neurodevelopmental processes. Neurosci Biobehav Rev 37:831\u2013845","journal-title":"Neurosci Biobehav Rev"},{"key":"9110_CR81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7334\/psicothema2012.327","volume":"25","author":"H Gonzalez-Pardo","year":"2013","unstructured":"Gonzalez-Pardo H, Perez AM (2013) Epigenetics and its implications for psychology. Psicothema 25:3\u201312","journal-title":"Psicothema"},{"key":"9110_CR82","volume-title":"Dopamine for dinner: an easy-to-follow 4 week meal plan to help break the cycle of addiction","author":"J Borsten","year":"2013","unstructured":"Borsten J (2013) Dopamine for dinner: an easy-to-follow 4 week meal plan to help break the cycle of addiction. Epicurus Press, Los Angeles"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9110-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9110-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:59:18Z","timestamp":1747771158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9110-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9110"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9110-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}